Impax Labs

FDA Bans Generics of Purdue's Older OxyContin Painkiller

FDA Bans Generics of Purdue's Older OxyContin Painkiller

Bloomberg

FDA Holds Up Impax Parkinson's Drug Approval Bid

FDA Holds Up Impax Parkinson's Drug Approval Bid

Motley Fool

Impax Fails to Win Approval for Parkinson’s Drug

Impax Fails to Win Approval for Parkinson’s Drug

Bloomberg

4 Can't-Miss Health-Care Events This Week

4 Can't-Miss Health-Care Events This Week

Motley Fool

Keep an Eye on These Five New Drugs in the First Quarter of 2013

Keep an Eye on These Five New Drugs in the First Quarter of 2013

Minyanville

FDA Pulls One Generic Form of Wellbutrin Off the Market

FDA Pulls One Generic Form of Wellbutrin Off the Market

Medline Plus

Impax signs development agreement with Perrigo

Impax signs development agreement with Perrigo

Yahoo/Fly on the Wall

First 90 Days of 2013 Are Live or Die For These Biotech Stocks

First 90 Days of 2013 Are Live or Die For These Biotech Stocks

TheStreet.com

Impax Laboratories Reports Third Quarter 2012 Results

Impax Laboratories Reports Third Quarter 2012 Results

Yahoo

Impax Labs says FDA extends review of Parkinson's disease drug Rytary by 3 months to Jan. 21

Impax Labs says FDA extends review of Parkinson's disease drug Rytary by 3 months to Jan. 21

Yahoo/AP